News

‘You could see the train wreck coming’: Inexperienced, dubious companies among many aiming to cash in on coronavirus antibody tests

Lax FDA oversight spurred a nascent industry of antibody test makers, with companies jockeying to cash in, a USA TODAY investigation found.